On June 30, 2015, a pharmaceutical conference “Localization in the Pharmaceutical Industry”, hosted by The Moscow Times, will take place in the Four Seasons Hotel Moscow (3 Okhotny Ryad). The official media partner is the analytical company RNC Pharma...

Rating of customs brokers clearing pharmaceutical drugs for import to Russia (January – April 2015)...

In April 2015, the Russian import of ready-made pharmaceutical drugs started to decrease, which is characteristic of that time of the year, but this year, it began a month earlier than usual. The volume of import fell by 14%, compared to March. In absolute terms, Russia imported 30.6 mln RUR worth of pharmaceutical drugs in April. In physical terms, the volume of import has decreased by 16% over the past year, which is also a sign of a downward trend...

Nearly 70 banks perform payment transactions of the import of pharmaceutical drugs to Russia, with the top-5 banks performing 69.4% of all the transactions made in the first quarter of 2015...

The beginning of the year for retail pharmacies was not only highlighted by further development of the economic crisis, demand fluctuation and a number of regulatory initiatives...

In March 2015, the volume of the Russian import of ready-made pharmaceutical drugs remained almost the same and amounted to 35.4 bln RUR. Over the year, the import expenditures has risen by 12%. However, the actual volume of import is decreasing, compared to March 2014, as it has fallen by 1.1% over the year...

On April 29, 2013, a new analytical company was registered with the unified state register of legal entity. This company was RNC Pharma. Everything went well, and the company was registered in the Interdistrict Inspection of the Russian Federal Tax Service #46...

In February 2015, Russia imported 35.2 bln RUR worth of ready-made pharmaceutical drugs, with the import expenditures rising by 22%, compared to 2014. The actual volume of import has fallen by 8.5% over the year, continuing the trend that started in January. As for the preferred currency, we can see the previous year’s trends returning – the percentage of contracts concluded in rubles has risen from 90% in January to 94% in February...

In the current economic and political environment, import substitution is one of the key drivers of the Russian pharmaceutical market. Soon, we can expect more than 70 Russian alternatives to 30 INNs out of the 57 strategically important pharmaceutical drugs alone. RNC Pharma presents the results of the research of import substitution and localization in the Russian pharmaceutical market...

On March 26, Moscow hosted a Russian Association of Pharmaceutical Marketing (RAPM) conference, “New Threats and Opportunities of Russian Pharmaceutical Market in 2015”. Within the agenda of the conference, RNC Pharma published a forecast of the Russian pharmaceutical market after the monetary crisis of 2014-2015...